18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
NCT03741231
·
clinicaltrials.gov ↗
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
NSCLC
Positron-Emission Tomography
Immunotherapy
18F-FDG
Sponsor
University Hospital, Brest